The Role of Microparticles as a Biomarker
Basic Study Information
The investigators propose to characterize MPs in aHUS and TTP both at the onset and
throughout treatment. The investigators believe that the number, size, and cell origin
will differ between these two diseases. The hypothesis is that endothelial derived
be higher in number and comprise a larger portion of the MP population in aHUS and
platelet MPs will comprise a larger number and greater proportion of MPs in TTP. The
investigators believe that MP identity and number can be used to reliably differentiate
between aHUS and TTP at disease onset.
Study Contact Information
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search